SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Zymeworks Inc. Investors.

NEW YORK, May 6, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors in Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME). Such investors are advised to get in touch Danielle Peyton at (email protected) or 646-581-9980, extension 7980

The investigation concerns whether Zymeworks and certain of its officers and/or directors engaged in securities transactions Fraud or other unlawful business practices.

(Click here for information about joining the class action lawsuit)

At April 1, 2024Zymeworks announced that it had been removed Christopher Astle (“Astle”) from the positions of Senior Vice President (“SVP”) and Chief Financial Officer (“CFO”) with immediate effect. Especially despite Zymeworks saying it has appointed its current president and chief executive officer Kenneth Galbraith While serving as interim CFO and initiating the search for a new CFO, the company could not provide reasons for Astle’s removal as SVP and CFO.

On this news, Zymeworks’ share price fell $0.64 per share or 6.08% to close $9.88 per share April 1, 2024.

Pomerantz LLP, with offices in new York, Chicago, Los Angeles, London, ParisAnd Tel Aviv, is considered one of the leading law firms in the areas of corporate, securities and antitrust litigation. Founded by the deceased Abraham L. PomerantzPomerantz, known as the dean of the class action bar, pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he founded and fights for the rights of securities victims Fraud, breaches of fiduciary duty and corporate misconduct. The company has recovered billions of dollars in damages on behalf of the class plaintiffs. See www.pomlaw.com.

Lawyer advertising. Previous results do not guarantee similar results.

CONTACT:
Danielle Peyton
Pomerantz LLP
(email protected)
646-581-9980 ext 7980

SOURCE Pomerantz LLP